Pregled bibliografske jedinice broj: 692728
Synthesis and preliminary evaluation of a 2- oxoquinoline carboxylic acid derivative for PET imaging the cannabinoid type 2 receptor
Synthesis and preliminary evaluation of a 2- oxoquinoline carboxylic acid derivative for PET imaging the cannabinoid type 2 receptor // Pharmaceuticals, 7 (2014), 3; 339-352 doi:10.3390/ph7030339 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 692728 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Synthesis and preliminary evaluation of a 2- oxoquinoline carboxylic acid derivative for PET imaging the cannabinoid type 2 receptor
Autori
Mu, Linjing ; Slavik, Roger ; Müller, Adrienne ; Popaj, Kasim ; Čermak, Stjepko ; Weber, Markus ; Schibli, Roger ; Krämer, Stefanie D. ; Ametamey, Simon M.
Izvornik
Pharmaceuticals (1424-8247) 7
(2014), 3;
339-352
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
cannabinoid receptor type 2 ligand ; CB2 receptor ; neurodegeneration ; radiolabeling ; autoradiography ; small-animal PET
Sažetak
Cannabinoid receptor subtype 2 (CB2) has been shown to be up-regulated in activated microglia and therefore plays an important role in neuroinflammatory and neurodegenerative diseases such as multiple sclerosis, amyotrophic lateral sclerosis and Alzheimer’s disease. The CB2 receptor is therefore considered as a very promising target for therapeutic approaches as well as for imaging. A promising 2-oxoquinoline derivative designated KP23 was synthesized and radiolabeled and its potential as a ligand for PET imaging the CB2 receptor was evaluated. [11C]KP23 was obtained in 10%–25% radiochemical yield (decay corrected) and 99% radiochemical purity. It showed high stability in phosphate buffer, rat and mouse plasma. In vitro autoradiography of rat and mouse spleen slices, as spleen expresses a high physiological expression of CB2 receptors, demonstrated that [11C]KP23 exhibits specific binding towards CB2. High spleen uptake of [11C]KP23 was observed in dynamic in vivo PET studies with Wistar rats. In conclusion, [11C]KP23 showed promising in vitro and in vivo characteristics. Further evaluation with diseased animal model which has higher CB2 expression levels in the brain is warranted.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Temeljne medicinske znanosti, Farmacija
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Emerging Sources Citation Index (ESCI)
- Scopus
Uključenost u ostale bibliografske baze podataka::
- CAB Abstracts
- CA Search (Chemical Abstracts)
- PubMed (NLM)
- Global Health (CABI)
- EMBASE (Elsevier)
- DOAJ